Answers are grounded in this paper and cite their sources.
Telogen effluvium (TE) is a common clinical consequence of medication-related alopecia. The inciting cause of TE may be difficult to identify due to delays in clinically apparent hair loss. Because medication-induced TE is a nonscarring alopecia that typically is reversible, appropriate management requires identification of the underlying triggering medication and cessation of it, if possible. In part 1 of this series, we review the existing literature on medication-induced TE with a focus on systemic retinoids, antifungal agents, and psychotropic medications.
No takes yet. Share an insight, caveat, or question.
Donglin Zhang (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: